22 May 2013
Keywords: merck, kgaa, 9b-euro, sale, generics, ops, mylan
Article | 17 December 2007
Darmstadt, Germany-based drugmaker Merck KGaA says that it has completed the sale of its worldwide generics business to Mylan Laboratories ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 December 2007
21 May 2013
© 2013 thepharmaletter.com